AMRX: Amneal Pharmaceuticals Inc - Class A

AMRX News

• The Motley Fool 20:39 Amneal (AMRX) Q2 EPS Jumps 56%
• Zacks 13:30 Amneal (AMRX) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
• Zacks 11:15 Amneal Pharmaceuticals (AMRX) Q2 Earnings Top Estimates
• Investing 10:22 Amneal Pharma A earnings beat by $0.08, revenue fell short of estimates
• Investing 10:19 Amneal Pharmaceuticals beats Q2 estimates, raises full-year outlook
• Zacks 18:07 Viatris Poised to Report Q2 Earnings: What's in Store for the Stock?
• Zacks 15:55 Nektar Gears Up to Report Q2 Earnings: What's in the Cards?
• Zacks 13:51 Bio-Techne Q4 Earnings Preview: What's in Store for the Stock?
• Zacks 16:45 Amneal (AMRX) is an Incredible Growth Stock: 3 Reasons Why
• Zacks 14:00 Amneal Pharmaceuticals (AMRX) Earnings Expected to Grow: Should You Buy?
• Zacks 13:55 Wall Street Analysts Think Amneal (AMRX) Could Surge 43.82%: Read This Before Placing a Bet
• Zacks 13:40 Is Amneal Pharmaceuticals (AMRX) Outperforming Other Medical Stocks This Year?
• Investing 01:28 Amneal Pharmaceuticals prices $600 million in senior secured notes, increases term loan
• Investing 11:46 Amneal seeks to borrow $1.8 billion in new term loans, offers notes
• Seeking Alpha 13:30 Jazz Pharmaceuticals: I See Big Potential In This Stock As An Investor (NASDAQ:JAZZ)
• Investing 12:13 Amneal reports positive phase 3 results for XOLAIR biosimilar
• Investing 20:15 Amneal Pharmaceuticals director Patel sells $761k in stock
• Seeking Alpha 09:42 Organon Stock: Persistent Headwinds Make This A Hold (NYSE:OGN)
• Investing 15:07 U.S. states join $7.4 billion Purdue Pharma, Sackler family settlement
• Investing 12:05 FDA approves Amneal’s prednisolone acetate eye drops, launch set for Q3
• Investing 17:34 Amneal Pharmaceuticals at Goldman Sachs Conference: Strategic Growth Vision
• Benzinga 17:31 Goldman Sachs Bullish On Branded Drug Upside At Teva: What About Viatris? - Viatris (NASDAQ:VTRS), Teva Pharmaceutical Indus (NYSE:TEVA), Amneal Pharmaceuticals (NASDAQ:AMRX)
• Investing 17:10 Goldman Sachs initiates coverage on generic drugmakers, sees upside in Teva and Am
• Investing 08:22 Goldman Sachs initiates Amneal Pharmaceuticals stock with neutral rating